Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konstantina Vogiatzi

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cardiovascular & Hematological Agents in Medicinal Chemistry|May 14, 2008
IL-1 cytokines in cardiovascular disease: diagnostic, prognostic and therapeutic implicationsStavros Apostolakis, Konstantina Vogiatzi, Elias Krambovitis, et al.
Cardiovascular Research|July 21, 2009
Interleukin 8 and cardiovascular diseaseStavros Apostolakis, Konstantina Vogiatzi, Virginia Amanatidou, et al.
Journal of Thrombosis and Thrombolysis|November 17, 2009
Angiotensin II up-regulates CX3CR1 expression in THP-1 monocytes: impact on vascular inflammation and atherogenesisStavros Apostolakis, Zacharenia Vlata, Konstantina Vogiatzi, et al.
Experimental and Therapeutic Medicine|February 15, 2013
Opposite effect of angiotensin receptor blockade on CXCL8 production and CXCR1/2 expression of angiotensin II-treated THP-1 monocytesKonstantina Vogiatzi, Stavros Apostolakis, Zaharenia Vlata, et al.
Journal of Thrombosis and Thrombolysis|May 1, 2009
Interleukin 8 gene polymorphisms and susceptibility to restenosis after percutaneous coronary interventionKonstantina Vogiatzi, Stavros Apostolakis, Vassilis Voudris, et al.
Journal of Clinical Immunology|April 4, 2008
Interleukin 8 and susceptibility to coronary artery disease: a population genetics perspectiveKonstantina Vogiatzi, Stavros Apostolakis, Vassilios Voudris, et al.
Thrombosis Research|February 10, 2009
Genetic diversity of RANTES gene promoter and susceptibility to coronary artery disease and restenosis after percutaneous coronary interventionKonstantina Vogiatzi, Vassilis Voudris, Stavros Apostolakis, et al.
Journal of Thrombosis and Thrombolysis|July 6, 2010
Genetic variability of the distal promoter of the ST2 gene is associated with angiographic severity of coronary artery diseaseAndy Tsapaki, Apostolos Zaravinos, Stavros Apostolakis, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cardiovascular & Hematological Agents in Medicinal Chemistry|May 14, 2008
IL-1 cytokines in cardiovascular disease: diagnostic, prognostic and therapeutic implicationsStavros Apostolakis, Konstantina Vogiatzi, Elias Krambovitis, et al.
Cardiovascular Research|July 21, 2009
Interleukin 8 and cardiovascular diseaseStavros Apostolakis, Konstantina Vogiatzi, Virginia Amanatidou, et al.
Journal of Thrombosis and Thrombolysis|November 17, 2009
Angiotensin II up-regulates CX3CR1 expression in THP-1 monocytes: impact on vascular inflammation and atherogenesisStavros Apostolakis, Zacharenia Vlata, Konstantina Vogiatzi, et al.
Experimental and Therapeutic Medicine|February 15, 2013
Opposite effect of angiotensin receptor blockade on CXCL8 production and CXCR1/2 expression of angiotensin II-treated THP-1 monocytesKonstantina Vogiatzi, Stavros Apostolakis, Zaharenia Vlata, et al.
Journal of Thrombosis and Thrombolysis|May 1, 2009
Interleukin 8 gene polymorphisms and susceptibility to restenosis after percutaneous coronary interventionKonstantina Vogiatzi, Stavros Apostolakis, Vassilis Voudris, et al.
Journal of Clinical Immunology|April 4, 2008
Interleukin 8 and susceptibility to coronary artery disease: a population genetics perspectiveKonstantina Vogiatzi, Stavros Apostolakis, Vassilios Voudris, et al.
Thrombosis Research|February 10, 2009
Genetic diversity of RANTES gene promoter and susceptibility to coronary artery disease and restenosis after percutaneous coronary interventionKonstantina Vogiatzi, Vassilis Voudris, Stavros Apostolakis, et al.
Journal of Thrombosis and Thrombolysis|July 6, 2010
Genetic variability of the distal promoter of the ST2 gene is associated with angiographic severity of coronary artery diseaseAndy Tsapaki, Apostolos Zaravinos, Stavros Apostolakis, et al.
Pageof 1